Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.0%

1 terminated out of 20 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

10%

2 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed with results

Key Signals

92% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (6)
P 1 (1)
P 2 (2)
P 3 (1)
P 4 (1)

Trial Status

Completed11
Unknown5
Active Not Recruiting2
Not Yet Recruiting1
Terminated1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT03929159Active Not RecruitingPrimary

Correlating MicroRNA Changes With Sepsis Outcomes

NCT01520597Completed

National Study on Listeriosis and Listeria

NCT05045963Completed

Impact of Aminoglycosides in Hypotensive Septic Oncology Patients

NCT07148440Not Yet RecruitingPrimary

Acid Base Disorders in ICU in Minia University Hospital

NCT05893420Not ApplicableActive Not Recruiting

A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning

NCT05040503Not ApplicableCompletedPrimary

Monitoring Mitophagy In Myeloid Cells Upon Intensive Care

NCT05358912Phase 4Completed

Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock

NCT04636554Unknown

Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia

NCT04764058Phase 1UnknownPrimary

Efficacy and Safety of Colistin Based Antibiotic Therapy

NCT03088865Not ApplicableCompletedPrimary

Evaluation of an Internal Hospital Practice: The Effect of Altered Test Tubes Sampling Order on Blood Culture Contamination Rates

NCT03943719CompletedPrimary

Clinical Impact of the FilmArray Blood Culture Identification Panel Performed on Positive Blood Cultures From Intensive Care Patients With Septicemia

NCT03583762Not ApplicableUnknownPrimary

Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique

NCT02988414Completed

Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious Disease Diagnostic Assay

NCT02093494Not ApplicableTerminatedPrimary

Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters

NCT02102087Not ApplicableCompletedPrimary

Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device

NCT00901940Phase 3Completed

Understanding the Immune Response to Meningitis Vaccines

NCT02069028Unknown

Effectiveness of Different Interventions for Implementing Surviving Sepsis Campaign (SSC) Guidelines on Compliance and Mortality: Systematic Review and Meta-analysis

NCT00258869Unknown

Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests

NCT00146432Phase 2CompletedPrimary

Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1)

NCT00046072Phase 2Completed

A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis

Showing all 20 trials

Research Network

Activity Timeline